characteristics.text: ERC000011
characteristics.characteristic: ENA-CHECKLIST
characteristics.text: 2019-10-25T04:04:49Z
characteristics.characteristic: ENA-FIRST-PUBLIC
characteristics.text: 2019-10-19T15:54:23Z
characteristics.characteristic: ENA-LAST-UPDATE
characteristics.text: SAMEA6101532
characteristics.characteristic: External Id
characteristics.text: OXFORD UNIVERSITY
characteristics.characteristic: INSDC center name
characteristics.text: 2019-10-25T04:04:49Z
characteristics.characteristic: INSDC first public
characteristics.text: 2019-10-19T15:54:23Z
characteristics.characteristic: INSDC last update
characteristics.text: public
characteristics.characteristic: INSDC status
characteristics.text: ERS3902217
characteristics.characteristic: SRA accession
characteristics.text: 8_S_kp4_evmc_ql_1
characteristics.characteristic: Submitter Id
characteristics.text: Yes
characteristics.characteristic: culture_enriched
characteristics.text: Vancomycin, metronidazole and cefpodoxime
characteristics.characteristic: enrichment_antibiotics
characteristics.text: 4
characteristics.characteristic: experiments
characteristics.text: QuickLyse Plasmid Kit
characteristics.characteristic: extraction method
characteristics.text: metagenome
characteristics.characteristic: organism
characteristics.text: B
characteristics.characteristic: participant
characteristics.text: metagenome
characteristics.characteristic: scientific_name
characteristics.text: K. pneumoniae
characteristics.characteristic: spike_organism
characteristics.text: 49700
characteristics.characteristic: spike_organism_concentration
characteristics.text: Fecal sample used in culture enrichment experiments
characteristics.characteristic: title